BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16837614)

  • 1. Urocortin expression is downregulated in human endometrial carcinoma.
    Florio P; De Falco G; Leucci E; Torricelli M; Torres PB; Toti P; Dell'Anna A; Tiso E; Santopietro R; Leoncini L; Petraglia F
    J Endocrinol; 2006 Jul; 190(1):99-105. PubMed ID: 16837614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma.
    Arcuri F; Cintorino M; Florio P; Floccari F; Pergola L; Romagnoli R; Petraglia F; Tosi P; Teresa Del Vecchio M
    Prostate; 2002 Aug; 52(3):167-72. PubMed ID: 12111693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process.
    Torricelli M; De Falco G; Florio P; Rossi M; Leucci E; ViganĂ² P; Leoncini L; Petraglia F
    Hum Reprod; 2007 Jan; 22(1):92-6. PubMed ID: 16920724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response.
    Novembri R; Carrarelli P; Toti P; Rocha AL; Borges LE; Reis FM; Piomboni P; Florio P; Petraglia F
    Mol Hum Reprod; 2011 Sep; 17(9):587-93. PubMed ID: 21454316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
    Otani T; Minami S; Yamoto M; Umesaki N
    Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
    Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
    Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
    Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
    J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
    Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
    Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin in the synovial tissue of patients with rheumatoid arthritis.
    Uzuki M; Sasano H; Muramatsu Y; Totsune K; Takahashi K; Oki Y; Iino K; Sawai T
    Clin Sci (Lond); 2001 Jun; 100(6):577-89. PubMed ID: 11352772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry.
    Kuo DY; Mallick S; Shen HJ; DeVictoria C; Jones J; Fields AL; Goldberg GL; Runowicz CD; Horwitz SB
    Clin Cancer Res; 1996 Dec; 2(12):1981-92. PubMed ID: 9816157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone receptor-1 in human endometrial cancer.
    Graziani G; Ferrandina G; Pozzoli G; Vergati M; Muzi A; Legge F; Tentori L; Scambia G; Navarra P
    Oncol Rep; 2006 Feb; 15(2):375-9. PubMed ID: 16391857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of urocortin in rat lung and its effect on pulmonary vascular permeability.
    Wu Y; Xu Y; Zhou H; Tao J; Li S
    J Endocrinol; 2006 Apr; 189(1):167-78. PubMed ID: 16614391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haptoglobin expression in endometrioid adenocarcinoma of the uterus.
    Nabli H; Tuller E; Sharpe-Timms KL
    Reprod Sci; 2010 Jan; 17(1):47-55. PubMed ID: 19801537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
    Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
    J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.
    Tezval H; Jurk S; Atschekzei F; Serth J; Kuczyk MA; Merseburger AS
    Prostate; 2009 Mar; 69(4):443-8. PubMed ID: 19058138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
    Soufla G; Sifakis S; Spandidos DA
    Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of maspin in endometrioid adenocarcinoma of endometrium.
    Li HW; Leung SW; Chan CS; Yu MM; Wong YF
    Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of urocortin in the extravillous human trophoblast at the implantation site.
    Bamberger CM; Minas V; Bamberger AM; Charalampopoulos I; Fragouli Y; Schulte HM; Makrigiannakis A
    Placenta; 2007; 28(2-3):127-32. PubMed ID: 16698078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis.
    Novembri R; Borges LE; Carrarelli P; Rocha AL; De Pascalis F; Florio P; Petraglia F
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1145-50. PubMed ID: 21289256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the expression and secretion of urocortin 2 in rat pituitary.
    Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T
    J Endocrinol; 2007 Feb; 192(2):443-52. PubMed ID: 17283244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.